Teneligliptin Hydrobromide
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Teneligliptin Hydrobromide Product Information
Teneligliptin Hydrobromide is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Teneligliptin. The product is supplied by Clearsynth under CAT No. CS-O-03625.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Teneligliptin Hydrobromide
CAS No.
906093-29-6
CAT No.
CS-O-03625
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C44H65Br5N12O2S2
Molecular Weight
1257.72
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Teneligliptin Hydrobromide is supplied with detailed characterization data compliant with regulatory guideline. Teneligliptin Hydrobromide can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Teneligliptin.
Overview
"Teneligliptin Hydrobromide (2:5) is a dipeptidyl peptidase-4 (DPP-4) inhibitor that is used to treat type 2 diabetes. It is eliminated via excretion, and has a half-life of 24.2 hours in the human body."
Synonyms
Teneligliptin Hydrobromide
Application Notes
"Teneligliptin Hydrobromide (2:5) is a dipeptidyl peptidase-4 (DPP-4) inhibitor that is used to treat type 2 diabetes. It is eliminated via excretion, and has a half-life of 24.2 hours in the human body."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.